Europlasma confirms its eligibility for the French PEA-PME regime

Read the press release (in French)

by a.borderes

Drawdown of 5 tranche of 100 convertible notes with warrants attached

Read the press release (in French)

by a.borderes

Set up of bond financing of up to € 100M over 7 years by OCABSA’s issuance to support the second phase of Europlasma's development

Read the press release (in French)

by a.borderes

Number of shares and voting rights as at 31/03/2021

Europlasma declares the number of voting rights and shares comprising its share capital as at 31st March.

Read the press release (in French)

by a.borderes

Drawdown of the last tranche 15 of 200 convertible notes

Read the press release (in French)

by c.fouere

Number of shares and voting rights as at 28/02/2021

Europlasma declares the number of voting rights and shares comprising its share capital as at 28th February.

Read the press release (in French)

by a.borderes

Extraordinary General Meeting of shareholders on 24/02/2021

Results

Read the press release (in French)

by a.borderes

Extraordinary General Meeting of shareholders on 24/02/2021

Ad hoc agent appointment

Read the press release (in French)

by a.borderes

Information relative to the Extraordinary General Meeting of shareholders on 24/02/2021

Read the press release (in French)

by a.borderes

Number of shares and voting rights as at 31/01/2021

Europlasma declares the number of voting rights and shares comprising its share capital as at 31st January.

Read the press release (in French)

by a.borderes